Prof. Dr. Thomas Klockgether

Prof. Dr. Thomas Klockgether

Neurologist

Graduation

University Hospital Bonn, Bonn – Germany University Hospital Bonn, Bonn – Germany

ChatYou are Viewing our Top Doctor

ChatChat on WhatsApp

About Prof. Dr. Thomas Klockgether

Prof. Dr. Thomas Klockgether is Professor and Head of the Department of Neurology at University Hospital Bonn, Germany, and Director of Clinical Research at the German Center for Neurodegenerative Diseases (DZNE), Bonn — a world authority on spinocerebellar ataxia, multiple system atrophy, Parkinson's disease, and neurodegenerative diseases, with 518+ scientific publications, Dean of the Medical Faculty University of Bonn (2008–2011), and recipient of the Holmes Prize from the Fondation de l'Ataxie cérébelleuse and the C3-Schilling Professorship.

  • Medical Degree — University of Göttingen (1974–1980); Habilitation & Board Certification in Neurology — University of Tübingen (1991); Research — Max Planck Institute (Parkinson's Disease); Dean, Medical Faculty — University of Bonn (2008–2011)
  • 45+ years of clinical and research experience; 518+ scientific publications; Head of Neurology — University Hospital Bonn (since 1998); Director of Clinical Research — DZNE Bonn; Head — Centre for Rare Diseases Bonn (ZSEB, since 2011); Head — Bonn International Graduate School of Clinical and Population Science (since 2015); 3,000+ inpatients treated annually at University Hospital Bonn Neurology Department
  • Holmes Prize — Fondation de l'Ataxie cérébelleuse (FAC); C3-Schilling Professorship for Theoretical and Clinical Medicine; world-leading ataxia, SCA, and multiple system atrophy specialist; FOCUS Magazine — Top Neurology Department in Germany

Qualifications & Credentials

Medical Degrees

  • Medical Degree (Graduation) — University of Göttingen, Göttingen, Germany, 1974–1980
  • Habilitation (Academic Venia Legendi) — University of Tübingen, Germany, 1991. Subject: Degenerative Ataxias and Neurodegeneration
  • Board Certification in Neurology — University of Tübingen, Germany, 1991

Research Appointments

  • Parkinson's Disease Research — Max Planck Institute, Germany
  • Clinical Training (Post-graduation) — Oldenburg, Germany
  • Specialist Training in Degenerative Ataxias — University of Tübingen, Germany (1987–1991)
  • Senior Physician and Lecturer — University of Tübingen, Germany (1991–1998, following Habilitation)

Academic Appointments

  • Professor and Chairman (Head) of Neurology — University Hospital Bonn, Germany (since 1998)
  • Dean — Medical Faculty, University of Bonn, Germany (2008–2011)
  • C3-Schilling Professorship for Theoretical and Clinical Medicine (awarded)
  • Director of Clinical Research — German Center for Neurodegenerative Diseases (DZNE), Bonn Site (since 2011)
  • Head — Centre for Rare Diseases Bonn (Zentrum für seltene Erkrankungen Bonn — ZSEB) (since 2011)
  • Head — Bonn International Graduate School of Clinical and Population Science (since 2015)

Areas of Expertise

Major Conditions Treated

  • Spinocerebellar Ataxia (SCA — all types)
  • Multiple System Atrophy (MSA)
  • Cerebellar Ataxia
  • Hereditary Spastic Paraplegia (HSP)
  • Parkinson's Disease
  • Dementia (Alzheimer's Disease, Other)
  • Cerebrovascular Disease (Stroke)
  • Multiple Sclerosis
  • Headache Disorders (Migraine, Cluster)
  • Neuromuscular Disorders

Sub-specialties

  • Spinocerebellar Ataxia & Degenerative Ataxias: World's foremost expert on spinocerebellar ataxia — leads the RISCA (Risk of Spinocerebellar Ataxia) natural history study investigating preclinical ataxia — a globally recognised spinocerebellar ataxia specialist University Hospital Bonn Germany for SCA1, SCA2, SCA3, SCA6, and other hereditary ataxias.
  • Multiple System Atrophy (MSA): Leading researcher and clinical specialist in MSA — Director of Clinical Research, DZNE Bonn — an expert multiple system atrophy neurologist Bonn Germany at one of Europe's premier neurodegenerative disease research and treatment centres.
  • Neurodegenerative Disease (Parkinson's, Dementia): Director of Clinical Research — DZNE (German Center for Neurodegenerative Diseases) — expert in preclinical detection and treatment of Parkinson's disease and dementia — a premier neurodegenerative disease specialist University Hospital Bonn Germany.

Advanced Procedures & Treatments

  • Neurological Examination & Complex Case Assessment
  • Genetic Testing & Counselling for Ataxias and Hereditary Neurological Diseases
  • MRI Brain / Spinal Cord (Advanced Neuroimaging)
  • Electromyography (EMG) & Nerve Conduction Studies (NCS)
  • EEG (Electroencephalography)
  • Cerebrospinal Fluid (CSF) Analysis
  • Multidisciplinary Ataxia Clinic (Rare Disease Centre ZSEB)
  • Clinical Trial Participation (DZNE — novel therapies for ataxias and MSA)
  • Preclinical Disease Detection (SCA Mutation Carriers)
  • Deep Brain Stimulation (DBS) Assessment for Movement Disorders

Professional Experience

Current Affiliation

  • University Hospital Bonn (Universitätsklinikum Bonn), Dept. of Neurology, Sigmund-Freud-Str. 25, 53105 Bonn, Germany — Professor and Head of Department (since 1998, Present)
  • German Center for Neurodegenerative Diseases (DZNE), Bonn — Director of Clinical Research (since 2011, Present)
  • Centre for Rare Diseases Bonn (ZSEB) — Head (since 2011, Present)

Key Leadership Roles

  • Dean — Medical Faculty, University of Bonn (2008–2011)
  • Head — Bonn International Graduate School of Clinical and Population Science (since 2015)
  • Section Editor — Experimental Neurology (2004–2008)
  • Study Lead — TreatHSP.net Consortium, Bonn Centre (Hereditary Spastic Paraplegia research)
  • Principal Investigator — RISCA Study (Risk of Spinocerebellar Ataxia — preclinical detection)

Key Achievements

  • 45+ years; 518+ scientific publications; 3,000+ inpatients annually
  • Professor and Head of Neurology — University Hospital Bonn (since 1998)
  • Dean — Medical Faculty, University of Bonn (2008–2011)
  • C3-Schilling Professorship; Holmes Prize (FAC)
  • FOCUS Magazine — University Hospital Bonn Neurology listed among top neurology departments in Germany
  • Certified by German Cancer Society for neuro-oncology

Awards & Recognitions

International Awards

  • Holmes Prize — Fondation de l'Ataxie cérébelleuse (FAC), France — for outstanding contributions to ataxia research
  • C3-Schilling Professorship for Theoretical and Clinical Medicine (University of Bonn)

Professional Memberships

  • German Medical Council (Ärztekammer) Registration
  • German Neurological Society (Deutsche Gesellschaft für Neurologie — DGN)
  • European Academy of Neurology (EAN)
  • European Federation of Neurological Societies (EFNS)
  • Member of various national and international ataxia and movement disorder research consortia

Research & Publications

Research Profile

  • 518+ peer-reviewed scientific publications in indexed international journals (confirmed via AiroMedical and DZNE profiles).
  • Research focus: Spinocerebellar ataxia (SCA), multiple system atrophy (MSA), cerebellar ataxia, Parkinson's disease, Alzheimer's disease, hereditary spastic paraplegia (HSP), and preclinical neurodegeneration.
  • RISCA Study — landmark study on preclinical spinocerebellar ataxia in mutation carriers.
  • Leads multiple DZNE clinical research programs linking basic neuroscience to patient care.

Estimated Treatment Costs

Procedure / ConsultationEstimated Cost (EUR)Estimated Cost (USD)
Neurology Consultation€200 – €500$220 – $550
Comprehensive Ataxia / SCA Evaluation€500 – €2,000$550 – $2,200
Genetic Testing (Ataxia Panel)€300 – €1,500$330 – $1,650
MRI Brain (Advanced Neuroimaging)€400 – €1,200$440 – $1,320
Second Opinion / Expert Review€500 – €1,500$550 – $1,650

*Indicative estimates only. Treatment at German public university hospitals is subject to statutory health insurance (GKV) or self-pay rates. Contact Cancer Rounds for a personalised cost estimate and international patient assistance.

Frequently Asked Questions

1. What is Prof. Dr. Thomas Klockgether known for?

Prof. Dr. Thomas Klockgether is the world's foremost expert on spinocerebellar ataxia (SCA) and a leading authority on multiple system atrophy (MSA), Parkinson's disease, and neurodegenerative diseases. He is Professor and Head of Neurology at University Hospital Bonn, Director of Clinical Research at the DZNE, and has 518+ publications. He received the Holmes Prize and C3-Schilling Professorship and served as Dean of Bonn's Medical Faculty (2008–2011).

2. What neurological conditions does Prof. Klockgether treat?

He treats spinocerebellar ataxia (all types), multiple system atrophy, hereditary spastic paraplegia, Parkinson's disease, dementia, cerebrovascular disease, multiple sclerosis, and headache disorders. International patients seeking the best neurologist in Bonn, Germany for rare movement disorders and ataxias consult him at University Hospital Bonn.

3. How do I book an appointment with Prof. Dr. Thomas Klockgether?

Appointments can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.

4. Can international patients receive treatment from Prof. Klockgether?

Yes. Cancer Rounds provides full assistance including travel coordination, medical visa support, and accommodation guidance for treatment in Bonn, Germany.

5. What support is available for international patients?

International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations.

6. Does Prof. Klockgether offer second opinions for neurological cases?

Yes. Second opinion and expert review consultations can be arranged via Cancer Rounds for patients with spinocerebellar ataxia, multiple system atrophy, Parkinson's disease, or other complex neurological conditions at University Hospital Bonn, Germany.

Our Impact

CancerRounds is making quality care accessible to patients around the world

Send your reports
5000+ Specialists
Send your reports
500+ Partner Hospitals
Send your reports
10000+ Patients Served
Send your reports
98% Patient Satisfaction

Why Choose CancerRounds for Your Treatment?

World-Class Care

World-Class Care Highly

Skilled oncologists provide top-tier medical services

Affordable Treatment

Affordable Treatment

Costs are significantly lower than in Western countries.

Comprehensive Packages

Comprehensive Packages

We offer all-inclusive plans covering surgery, stay, and aftercare.

Easy Accessibility

Easy Accessibility

Well-connected airports and international flight routes. Proven Success: High patient satisfaction and positive treatment outcomes

Proven Success

Proven Success

High patient satisfaction and positive treatment outcomes


    Get FREE Evaluation

    Treatment plan and quote within 2 days

    FREE, No-Obligation Expert Evaluation

    👥 Trusted by Over 10,000 Patients Worldwide

    🤝 Expert Handholding at Every Step

    Your information is safe and confidential.